Skip to content Skip to footer

Elevated Lipoprotein(a) Clinical Trials

Because Every Step in Research Brings Us Closer to Better Heart Health

Concerned About Elevated Lipoprotein(a)?

Explore Clinical Trials That Could Shape Future Treatments

Lp(a) is a cholesterol-carrying particle in the blood that is largely determined by genetics. High levels of Lp(a) are associated with a higher risk of atherosclerotic cardiovascular disease (ASCVD), including heart attack, stroke, and peripheral artery disease. Unlike other lipids, Lp(a) levels are not significantly reduced by lifestyle changes or standard cholesterol-lowering therapies.

Revival Research Institute is conducting elevated lipoprotein(a) clinical trials to explore potential new therapies. These studies aim to evaluate the safety and effectiveness of treatments that may lower Lp(a) levels and reduce cardiovascular risk. If you are in Texas, you may be eligible to participate in an elevated lipoprotein(a) clinical trial in Texas.

Are You Eligible to Participate?

To be eligible for our clinical trial for high lipoprotein(a), individuals must meet the following criteria:

*Additional criteria may apply.

Participation in elevated lipoprotein(a) clinical trials provides a chance to receive expert care, free study-related medication, and regular health monitoring by experienced medical professionals.

This field is for validation purposes and should be left unchanged.
Who is this information for?*(Required)

Please provide YOUR contact information only.

Name(Required)
Best Time to Call(Required)
User Agreement(Required)
This is our Privacy Policy.

Elevated Lipoprotein Flyer

About the Clinical Trials for Elevated Lp(a)

Elevated Lipoprotein(a), or Lp(a), is a genetic lipid condition that can’t be managed through diet, exercise, or most cholesterol medications. High levels of Lp(a) can lead to a buildup of plaque in the arteries, increasing the risk of heart attack, stroke, and other cardiovascular events.

Revival Research Institute is conducting clinical trials to evaluate an investigational therapy designed to specifically target and lower Lp(a) levels.

All study-related care, including medical evaluations, lab tests, and investigational medication, is provided at no cost, and insurance is not required to participate. Eligible participants may also receive compensation for their time and travel.

If you’re interested in learning more, complete the form above, and a member of our research team will contact you to discuss your eligibility. A brief conversation about your health and medical history will help determine if a clinical trial may be right for you.

Get Started
What to Expect?

If you are living with elevated lipoprotein(a), you may qualify for a paid clinical trial exploring potential treatment options. After completing the interest form above, a research team member will contact you for a brief pre-screening to review your health history and determine eligibility.

If you appear eligible, you’ll be invited to a screening visit at our clinical research site. During this visit, medical staff will review your history, perform basic exams, and run lab tests to confirm eligibility. Before any procedures begin, you’ll be asked to review and sign an Informed Consent Form (ICF) that outlines the study’s purpose, procedures, and potential risks and benefits.

Our team will ensure you fully understand your role in the study and what to expect throughout participation. You are encouraged to ask questions at any stage. Your participation helps advance research toward future treatment options for elevated Lp(a).

Age Icon
Age
18 years or older
Condition Icon
Condition
Elevated Lipoprotein(a)
Location Icon
Location
Texas 

Understanding Elevated Lipoprotein(a)

Elevated Lipoprotein a Clinical Trials

Lipoprotein(a), or Lp(a), is a type of lipid in the blood made up of cholesterol, a protein called apolipoprotein(a), and low-density lipoprotein (LDL). Elevated Lp(a) levels are almost entirely inherited and not significantly affected by diet, exercise, or lifestyle.

Causes of Elevated Lp(a)

Risks and Symptoms of Elevated Lp(a)

Currently, there are no FDA-approved treatments specifically for lowering Lp(a). That’s why participation in elevated lipoprotein(a) clinical trials is critical to developing therapies that may improve long-term cardiovascular outcomes.

Frequently Asked Questions

Your Guide to Common Questions

We’ve gathered answers to some of the most common questions about what causes elevated Lp(a), how it can be managed, and what steps you can take to protect your heart health. Still have questions? Our team is here to help. Call us at +1 (248) 721-9539 — we’ll be happy to assist you.

Lp(a) is a type of cholesterol particle in the blood. High levels increase the risk of cardiovascular disease and are primarily inherited.

Genetics is the main cause. Unlike other cholesterol levels, Lp(a) is not affected by lifestyle, diet, or exercise.

It is diagnosed through a simple blood test measuring Lp(a) levels.

There are currently no approved treatments. Ongoing clinical trials for high lipoprotein(a) are studying investigational therapies that may significantly lower Lp(a) levels.

Joining a clinical trial may give you access to investigational therapies, free expert care, and the chance to contribute to research that could change the future of cardiovascular health.